| 영문 | candidiasis | 한글 | 칸디다증 |
|---|---|---|---|
| 설명 | 곰팡이의 하나인 candida에 의한 감염. 대개 피부의 감염이 가장 흔하고, 신생아의 입이나 여성의 질에 감염을 일으키기도 한다. 그리고 아주 드물게 칸디다가 전신적 감염을 일으키기도 한다. 이것을 모닐리아증(moniliasis)이라고도 한적 있다. |
||
| APECED | Autoimmune Poly-Endocrinopathy Candidiasis Ectodermal Dystrophy |
|---|---|
| MEDAC Syndrome | Multiple-Endocrine Deficiency Autoimmune-Candidiasis |
| CMC | carboxymethylcellulose; care management continuity; carpometacarpal; cell-mediated cytolysis or cyto... |
| CMCC | chronic mucocutaneous candidiasis |
| FCMC | familial chronic mucocutaneous candidiasis; family centered maternity care |
| APECED | Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy |
|---|---|
| CMC | Chronic mucocutaneous candidiasis |
| OC | Oral candidiasis |
| OPC | Oropharyngeal candidiasis |
| VVC | Vulvovaginal candidiasis |
| candidiasis | <gastroenterology, microbiology, oncology> Infection with a fungus of the genus Candida. It is usually a superficial infection of the moist cutaneous areas of the body and is generally caused by Candida albicans, it most commonly involves the skin (dermatocandidiasis), oral mucous membranes (oral candidiasis), respiratory tract (bronchocandidiasis) and vagina (vaginal candidiasis or thrush). Rarely there is a systemic infection or endocarditis. Oral candidiasis: describes a fungal (yeast) infection of the oral cavity due to Candida. It is common in infants, diabetics or those on chemotherapy and is well recognised in patients with HIV infection and AIDS. Oesophageal candidiasis: Infection of the oesophagus by the yeast-like fungus Candidal albicans. Usually occurs in the immunocompromised individual (AIDS or following chemotherapy). Oral candidiasis is a predisposing factor but oesophageal involvement can occur without evidence of infection in the oral cavity. Symptoms include difficulty swallowing, pain on swallowing and oral lesions. Diagnosis is made using endoscopy. Treatment is with antifungal agents such as ketoconazole or fluconazole. Synonym: moniliasis, candidosis, oidiomycosis, blastodendriosis. (16 Dec 1997) |
|---|---|
| candidiasis, chronic mucocutaneous | A clinical syndrome characterised by development, usually in infancy or childhood, of a chronic, often widespread candidiasis of skin, nails, and mucous membranes. It may be secondary to one of the immunodeficiency syndromes, inherited as an autosomal recessive trait, or associated with defects in cell-mediated immunity, endocrine disorders, dental stomatitis, or malignancy. (12 Dec 1998) |
| candidiasis, cutaneous | Candidiasis of the skin manifested as eczema-like lesions of the interdigital spaces, perleche, or chronic paronychia. (12 Dec 1998) |
| candidiasis of oesophagus | <radiology> Findings: long oesophageal segments involved (more common in lower 1/2), 1-2 mm nodular filling defects with linear orientation (plaques), cobble stone: mucosal nodularity in early stage, shaggy, fuzzy, serrated contour (from pseudomembranes, erosions, ulcerations, intramural hemmorhage), narrowed lumen (spasm, pseudomembrane, oedema), intramural diverticulosis, sluggish/absent peristalsis Differential diagnosis: reflux oesophagitis, herpes oesophagitis, acute caustic ingestion, intramural pseudotics, squamous papillomatosis, glycogen acanthosis, Barrett oesophagus, superficial spreading carcinoma, epidermolysis bullosa, varices diagnostic sensitivity: endoscopy (97%), double contrast (88%), single contrast (55%) (12 Dec 1998) |
| candidiasis, oral | Infection of the mucous membranes of the mouth by a fungus of the genus candida. (12 Dec 1998) |
| candidiasis, vulvovaginal | Infection of the vulva and vagina with a fungus of the genus candida. (12 Dec 1998) |
| oesophageal candidiasis | <gastroenterology, microbiology, oncology> Infection with a fungus of the genus Candida. It is usually a superficial infection of the moist cutaneous areas of the body and is generally caused by Candida albicans, it most commonly involves the skin (dermatocandidiasis), oral mucous membranes (oral candidiasis), respiratory tract (bronchocandidiasis) and vagina (vaginal candidiasis or thrush). Rarely there is a systemic infection or endocarditis. Oral candidiasis: describes a fungal (yeast) infection of the oral cavity due to Candida. It is common in infants, diabetics or those on chemotherapy and is well recognised in patients with HIV infection and AIDS. Oesophageal candidiasis: Infection of the oesophagus by the yeast-like fungus Candidal albicans. Usually occurs in the immunocompromised individual (AIDS or following chemotherapy). Oral candidiasis is a predisposing factor but oesophageal involvement can occur without evidence of infection in the oral cavity. Symptoms include difficulty swallowing, pain on swallowing and oral lesions. Diagnosis is made using endoscopy. Treatment is with antifungal agents such as ketoconazole or fluconazole. Synonym: moniliasis, candidosis, oidiomycosis, blastodendriosis. (16 Dec 1997) |
| oral candidiasis | <gastroenterology, microbiology, oncology> Infection with a fungus of the genus Candida. It is usually a superficial infection of the moist cutaneous areas of the body and is generally caused by Candida albicans, it most commonly involves the skin (dermatocandidiasis), oral mucous membranes (oral candidiasis), respiratory tract (bronchocandidiasis) and vagina (vaginal candidiasis or thrush). Rarely there is a systemic infection or endocarditis. Oral candidiasis: describes a fungal (yeast) infection of the oral cavity due to Candida. It is common in infants, diabetics or those on chemotherapy and is well recognised in patients with HIV infection and AIDS. Oesophageal candidiasis: Infection of the oesophagus by the yeast-like fungus Candidal albicans. Usually occurs in the immunocompromised individual (AIDS or following chemotherapy). Oral candidiasis is a predisposing factor but oesophageal involvement can occur without evidence of infection in the oral cavity. Symptoms include difficulty swallowing, pain on swallowing and oral lesions. Diagnosis is made using endoscopy. Treatment is with antifungal agents such as ketoconazole or fluconazole. Synonym: moniliasis, candidosis, oidiomycosis, blastodendriosis. (16 Dec 1997) |
| anterior intestinal portal | Anterior intestinal portal; the opening of the foregut into the midgut. See: epigastric fossa. Synonym: anterior intestinal portal. (05 Mar 2000) |
| gas, intestinal | The complaint referred to as intestinal gas is a common one and the discomfort can be quite significant. Everyone has gas and eliminates it by burping or passing it through the rectum. In many instances people think they have too much gas when in reality they have normal amounts. most people produce 1 to 3 pints of intestinal gas in 24 hours and pass gas an average of 14 times a day. It is made up primarily of odourless vapors such as carbon dioxide, oxygen, nitrogen, hydrogen, and in some families, methane. The unpleasant odour is due to bacteria in the large intestine that release small amounts of gases containing sulfur. (12 Dec 1998) |
| vasoactive intestinal contractor | Mouse homologue of endothelin 2. (18 Nov 1997) |
| vasoactive intestinal peptide | <gastroenterology, protein> Peptide of 28 amino acids, originally isolated from porcine intestine, but later found in the central nervous system where it acts as a neuropeptide and is released by specific interneurons. May also affect behaviour of cells of the immune system. Acronym: VIP (05 Jan 1998) |
| vasoactive intestinal polypeptide | A polypeptide hormone secreted most commonly by non-beta islet cell tumours of the pancreas, producing copious watery diarrhoea and faecal electrolyte loss, particularly hypokalaemia; VIP increases the rates of glycogenolysis; stimulates pancreatic bicarbonate secretion. Synonym: vasoactive intestinal peptide. (05 Mar 2000) |
| receptors, vasoactive intestinal peptide | Cell surface proteins that bind vasoactive intestinal peptide (vip) with high affinity and trigger intracellular changes which influence the behaviour of cells. (12 Dec 1998) |
| megacystitis-microcolon-intestinal hypoperistalsis syndrome | <syndrome> A rare condition characterised by abdominal distention, lax abdominal musculature, incomplete intestinal rotation, and deficient intestinal peristalsis. A large bladder and often vesicoureteral reflux are seen. Typically affects female neonates and usually fatal in first year of life. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|